< 1 minute read
Dec. 16, 2021

GSK852: a BET BD2 inhibitor

GSK852

1000x BD2-selective BET bromodomain inh. orally available in dog rational design from prior lead Journal of Medicinal Chemistry GlaxoSmithKline, Stevenage, UK

twitterlinkedinprintemail